S-1/A - Panbela Therapeutics, Inc. (0001029125) (Filer)

1 min to read

S-1/A – Panbela Therapeutics, Inc. (0001029125) (Filer)

Filed: 2022-12-27 AccNo: 0001437749-22-029781 Size: 1 MB
Source: S-1/A – Panbela Therapeutics, Inc. (0001029125) (Filer)

Form PRE 14A Target Global Acquisitio For: Nov 24 – StreetInsider.com

Form PRE 14A Target Global Acquisitio For: Nov 24 StreetInsider.com Source: Form PRE 14A Target Global Acquisitio For: Nov 24 -...
NextEra Energy and NextEra Energy Partners to meet with investors … – PR Newswire

NextEra Energy and NextEra Energy Partners to meet with investors ... PR Newswire Source: NextEra Energy and NextEra Energy Partners to...
Spatial OMICS Market Research Report 2023 – Global Forecast to … – Business Wire

Spatial OMICS Market Research Report 2023 - Global Forecast to ... Business Wire Source: Spatial OMICS Market Research Report 2023 -...
Augmentum Fintech Plc – Half-year Report -November 28, 2023 at … – Marketscreener.com

Augmentum Fintech Plc - Half-year Report -November 28, 2023 at ... Marketscreener.com Source: Augmentum Fintech Plc - Half-year Report -November 28,...
Digital World Reports Mounting Losses in Amended Annual Report

Digital World Acquisition, the SPAC that has been trying for two years to merge with Trump Media and Technology Group,...